Skip to main content

Food safety screening: synthetic glucocorticoids

Objective

The proposal aims to facilitate and catalyse the accelerated development of promising vaccine strategies from the laboratory to the clinic. The urgent need of a vaccine to prevent AIDS requires the most efficient utilisation of nonhuman primate resources to evaluate, select and refine the most promising AIDS vaccine candidates for clinical trials. The standardised evaluation of HIV-1 vaccine candidates for safety, immunogenicity and efficacy will be carried out under very controlled conditions in an unbiased fashion in well characterised non-human primates. This data will be constantly fed back to vaccine developers to assist them to accelerate development, to optomise vaccine components, and to refine immunisation protocols for clinical trials with greatest chance of success. A large number of new and innovative vaccine candidates and immunisation strategies will be evaluated.

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

GENT UNIVERSITY
Address
Sint Pietersnieuwstraat 25
9000 Gent
Belgium

Participants (5)

Business Unit of TNO Built Environment and Geosciences
Netherlands
Address
Van Mourik Broekmanweg 6
2628 XE Delft
EURO-DIAGNOSTICS BV - HEALTH BIOTECHNOLOGY
Netherlands
Address
Beyerinekweg
6802 EA Arnhem
INSTITUTE OF HEALTH CARLOS III
Spain
Address
Calle Sinesio Delgardo 6
28029 Madrid
THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom
Address
Stoney Road , Stormont
BT4 3SD Belfast
UNIVERSITY OF ZURICH
Switzerland
Address
71,Raemistrasse 71
CH-8091 Zurich